1425944-20-2

Upstream product

• 90-02-8 salicylaldehyde 
• 607-57-8 2-nitro-9H-fluorene 
• 906440-37-7 2-(2-nitro-fluoren-9-ylidenemethyl)phenol 

Downstream Products

• 1425944-25-7 1-(4-fluoro-benzenesulfonyl)-4-{2-[2-(2-nitro-fluoren-9-ylidenemethyl)-phenoxy]-ethyl}-piperazine 
• 1425944-26-8 1-(4-(2-(2-((2-nitro-9H-fluoren-9-ylidene)methyl)phenoxy)ethyl)piperazin-1-yl)ethan-1-one 
• 1425944-27-9 1-cyclopropanesulfonyl-4-{2-[2-(2-nitro-fluoren-9-ylidenemethyl)-phenoxy]-ethyl}-piperazine 

Relevant academic research and scientific papers

BAX AGONIST, COMPOSITIONS, AND METHODS RELATED THERETO

The disclosure relates to BAX activators and therapeutic uses relates thereto. In certain embodiments, the disclosure relates to methods of treating or preventing cancer, such as lung cancer, comprising administering a therapeutically effective amount of a pharmaceutical composition comprising a compound disclosed herein or pharmaceutically acceptable salt to a subject in need thereof.